| Recruiting | A Study of Duvelisib Versus Gemcitabine or Bendamustine in Participants With Relapsed/Refractory Nodal T Cell Lymphoma | Phase 3 | 2025-05-19 |
| Terminated | A Study of Duvelisib in Combination With Pembrolizumab in Head and Neck Cancer Head and Neck Squamous Cell Carcinoma | Phase 1 / Phase 2 | 2020-06-01 |
| Terminated | Observational Trial of Real-World Treatment Utilization and Effectiveness of PI3K-inhibitors in CLL/SLL and FL Lymphoma, Small Lymphocytic, Lymphoma, Lymphoma, Non-Hodgkin | — | 2020-04-23 |
| Completed | A Phase 2 Study Comparing 2 Intermittent Dosing Schedules of Duvelisib in Participants With Indolent Non-Hodgk Indolent Non-Hodgkin Lymphoma | Phase 2 | 2019-09-24 |
| Completed | A Study of Duvelisib in Participants With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) Peripheral T-cell Lymphoma | Phase 2 | 2018-02-22 |
| Withdrawn | Phase 2 Study of Duvelisib in Previously Treated Patients With Chronic Lymphocytic Leukemia /Small Lymphocytic Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 2 | 2018-02-12 |
| Completed | A Long-term, Continued Treatment and Follow-up Study in Participants With Hematologic Malignancies Treated Wit Hematologic Malignancy | Phase 2 | 2016-04-01 |
| Withdrawn | A Study of Duvelisib in Combination With Rituximab and Bendamustine vs Placebo in Combination With Rituximab a Indolent Non-Hodgkin's Lymphoma, Follicular Lymphoma, Small Lymphocytic Lymphoma | Phase 3 | 2015-12-01 |
| Withdrawn | Duvelisib With Rituximab vs R-CHOP in Subjects With Relapsed/Refractory Follicular Lymphoma (FRESCO) Lymphoma | Phase 2 | 2015-12-01 |
| Terminated | Duvelisib With Obinutuzumab in Patients With CLL/SLL Previously Treated With a BTKi (SYNCHRONY) Lymphocytic Leukemia, Chronic, Lymphoma, Small Lymphocytic | Phase 1 | 2015-02-01 |
| Terminated | A Study of Duvelisib in Combination With Rituximab or Obinutuzumab in Subjects With Previously Untreated CD20+ CD20+ Follicular Lymphoma | Phase 1 / Phase 2 | 2014-12-01 |
| Completed | Bioequivalence of Duvelisib and Food Effect on Pharmacokinetics of IPI-145 Healthy | Phase 1 | 2014-11-01 |
| Terminated | Study of Duvelisib in Combination With Rituximab vs Rituximab in Subjects With Previously Treated Follicular L Follicular Lymphoma | Phase 3 | 2014-09-01 |
| Completed | Duvelisib in Hepatically Impaired Subjects Compared to Healthy Subjects Hepatic Impairment | Phase 1 | 2014-03-01 |
| Completed | A Phase 3 Extension Study of Duvelisib and Ofatumumab in Participants With CLL/SLL Previously Enrolled in Stud Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 3 | 2013-12-01 |
| Completed | A Phase 3 Study of Duvelisib Versus Ofatumumab in Patients With Relapsed or Refractory CLL/SLL (DUO) Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 3 | 2013-11-01 |
| Completed | Phase 1 Study in Healthy Subjects to Evaluate the Effect of Rifampin on the Pharmacokinetics of IPI-145 Healthy | Phase 1 | 2013-10-01 |
| Completed | Phase 1 Study in Healthy Subjects to Evaluate the Effect of IPI-145 on the Pharmacokinetics of Midazolam Healthy | Phase 1 | 2013-08-01 |
| Completed | A Study of Duvelisib in Participants With Refractory Indolent Non-Hodgkin Lymphoma Indolent Non-Hodgkin Lymphoma | Phase 2 | 2013-06-17 |
| Completed | A Double-Blind Study Evaluating Duvelisib in Subjects With Moderate to Severe Rheumatoid Arthritis and an Inad Rheumatoid Arthritis | Phase 2 | 2013-04-01 |
| Completed | IPI-145 ADME and Absolute Bioavailability Study Healthy | Phase 1 | 2013-03-01 |
| Completed | A Phase 2a, Efficacy and Safety Study of Duvelisib in Mild Asthmatic Subjects Asthma | Phase 2 | 2012-07-01 |
| Terminated | A Phase 1 Study of Duvelisib in Patients With Advanced Hematologic Malignancies Hematologic Malignancies | Phase 1 | 2011-10-01 |
| Completed | IPI-145 Single Ascending, Multiple Ascending, Food Effect and Drug-Drug-Interaction Study Healthy Volunteers | Phase 1 | 2011-08-01 |